Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subjective Well Being of Patients Receiving Atypical Antipsychotics as Monotherapy or Cotherapy With Mood Stabilizers

NCT00691353 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00691353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00691353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subjective Well Being of Patients Receiving Atypical Antipsychotics as Monotherapy or Cotherapy With Mood Stabilizers
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 30, 2008
Completion date
July 31, 2008
Enrollment
540 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder